| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.54 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |